7 The ADA continues to recommend metformin in conjunction with lifestyle interventions as first-line therapy in patients with T2D
The same principle applies to digestive symptoms
Cagrilintide Semaglutide is a combination of two different peptides: semaglutide, which is already known for its powerful effects on weight loss and blood sugar, and cagrilintide, which works a little differently to help control appetite
Louisiana is the only state not currently served
GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro are increasingly prescribed for obesity and type 2 diabetes due to their proven effectiveness in reducing appetite, promoting weight loss, and lowering blood glucose levels.(1, 2) These medications have become extremely popular, fueled by extensive marketing to both healthcare providers and the public